Inventor
GEBERT ULRICH
DE31 patents
⚠️ This page may combine multiple inventors who share the name “GEBERT ULRICH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOECHST AG
26 patentsUS5965555AOct 12, 1999
Xanthine compounds having terminally animated alkynol side chains
HOECHST AG81 citations95
US4833146AMay 23, 1989
Tertiary hydroxyalkylxanthines, medicaments containing them and their use
HOECHST AG58 citations95
US4213994AJul 22, 1980
Imidazolyl-(2)-carbinols having hypolipidemic action and process for preparing them
HOECHST AG29 citations82
US5310666AMay 10, 1994
Process for the enantioselective preparation of (β-1)-hydroxyalkylxanthines by reduction using Rhodotorula rubra
HOECHST AG15 citations81
US4404384ASep 13, 1983
O-[3-(4-Substituted-piperazin-1-yl)-2-hydroxypropyl]-hydroxylamines
HOECHST AG24 citations79
US4891374AJan 2, 1990
Imidazo- and triazolothiadiazines
HOECHST AG7 citations73
US4713455ADec 15, 1987
Cyclic derivatives of alkyl dihydroxyalkylxanthenes
HOECHST AG13 citations73
US6214992B1Apr 10, 2001
Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation
HOECHST AG10 citations72
US5006515AApr 9, 1991
Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein
HOECHST AG7 citations72
US4616020AOct 7, 1986
Medicaments, vicinal dihydroxyalkylxanthines contained therein, processes for the preparation of these xanthine compounds and intermediate products suitable for these
HOECHST AG11 citations72
US4216216AAug 5, 1980
Aromatic piperazinyl substituted dihydrouracils
HOECHST AG10 citations72
US4152440AMay 1, 1979
Novel derivatives of imidazole, and pharmaceutical compositions containing them
HOECHST AG13 citations72
US4358450ANov 9, 1982
O-Alkylated oximes and pharmaceutical composition thereof
HOECHST AG7 citations69
US5409935AApr 25, 1995
Xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas
HOECHST AG18 citations68
US4235899ANov 25, 1980
Substituted O-(2-hydroxypropyl)-aldoximes
HOECHST AG3 citations63
US5710272AJan 20, 1998
7-methoxymethly-3-methyl-1-(5-oxohexyl)xanthine
HOECHST AG2 citations62
US4940790AJul 10, 1990
5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6H-1,3,4-thiadiazines
HOECHST AG4 citations62
US4908364AMar 13, 1990
Substituted 3-phenyl-7H-thiazol[3,2-b][1,2,4]-triazin-7-ones
HOECHST AG3 citations62
US4258046AMar 24, 1981
Pyrano-heterocycles and medicaments containing these compounds
HOECHST AG2 citations62
US4150043AApr 17, 1979
0-(2,3-Epoxypropyl)-hydroximic acid esters
HOECHST AG3 citations62
US3951963AApr 20, 1976
0-(Substituted-aminoalkyl)-5-nitroimidazole-(2)-aldoximes
HOECHST AG3 citations62
US5478831ADec 26, 1995
R-(-)1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its preparation and pharmaceuticals containing this compound
HOECHST AG1 citations61
US4213986AJul 22, 1980
Novel derivatives of imidazole and pharmaceutical compositions containing them and method of use
HOECHST AG6 citations61
US5472873ADec 5, 1995
Rhodotorula rubra useful in a process for the preparation of (ω-1)-hydroxyalkylxanthines
HOECHST AG0 citations51
US5407815AApr 18, 1995
R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its preparation and pharmaceuticals containing this compound
HOECHST AG1 citations51
US5922868AJul 13, 1999
Use of xanthine derivatives for the treatment of nerve damage following an interruption in blood circulation
HOECHST AG0 citations47
AVENTIS PHARMA GMBH
2 patentsUS6432968B1Aug 13, 2002
Combination preparation, containing cyclosporin a or FK506 or rapamycin and a xanthine derivative
AVENTIS PHARMA GMBH19 citations90
US6046328AApr 4, 2000
Combination preparation, containing cyclosporin A or FK506 or rapamycin and a xanthine derivative
AVENTIS PHARMA GMBH8 citations71